Finny logo
Finny logo
Alexion Pharmaceuticals, Inc. (ALXN)
82
  • CONTENT
  • SOURCES
Alexion Pharmaceuticals, Inc. Expected to Earn Q3 2020 Earnings of $2.33 Per Share (NASDAQ:ALXN)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) – Investment analysts at Wedbush reduced their Q3 2020 earnings per share (EPS) estimates for shares of Alexion Pharmaceuticals in a report released on Monday, October 19th. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will earn $2.33 per share for the quarter, down from their previous forecast of […]
Alexion Pharmaceuticals, Inc. Forecasted to Earn Q3 2020 Earnings of $2.51 Per Share (NASDAQ:ALXN)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) – Equities research analysts at SVB Leerink increased their Q3 2020 EPS estimates for shares of Alexion Pharmaceuticals in a report issued on Wednesday, October 21st. SVB Leerink analyst G. Porges now forecasts that the biopharmaceutical company will post earnings of $2.51 per share for the quarter, up from their prior […]
Alexion Pharmaceuticals (ALXN) Scheduled to Post Quarterly Earnings on Thursday
Alexion Pharmaceuticals (NASDAQ:ALXN) will be issuing its quarterly earnings data before the market opens on Thursday, October 29th. Analysts expect the company to announce earnings of $2.33 per share for the quarter. Alexion Pharmaceuticals has set its FY 2020 Pre-Market guidance at 10.65-10.95 EPS.Investors that wish to listen to the company’s conference call can do […]
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to Post Q3 2020 Earnings of $2.33 Per Share, Wedbush Forecasts
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) – Equities researchers at Wedbush lowered their Q3 2020 earnings estimates for shares of Alexion Pharmaceuticals in a report issued on Monday, October 19th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of $2.33 per share for the quarter, down from their previous forecast of $2.37. […]
Genetic Disorders Market to Grow at a CAGR of 13.68%, Leading Players Amicus Therapeutics, Inc.; Alexion Pharmaceuticals, Inc.; Sanofi; Takeda Pharmaceutical Company Limited; Vertex Pharmaceuticals Incorporated
Genetic Disorders Market is expected to register a healthy CAGR of 13.68% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be
Brokerages Anticipate Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to Post $2.59 Earnings Per Share
Wall Street brokerages forecast that Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) will post earnings per share (EPS) of $2.59 for the current quarter, Zacks reports. Ten analysts have provided estimates for Alexion Pharmaceuticals’ earnings, with estimates ranging from $2.42 to $3.00. Alexion Pharmaceuticals reported earnings per share of $2.79 during the same quarter last year, which would […]
Orphan Drugs Market with (Covid-19) Impact Analysis: Top Industry Trends & Segments Forecast 2020-2027 | Bayer HealthCare Pharmaceuticals , Vertex Pharmaceuticals, Merck & Co., Alexion Pharmaceuticals
Orphan drugs are specialized pharmaceutical agents that are administered for treatment of rare (orphan) diseases. These diseases have a very low prevalence rate, hence, pharmaceutical companies do not readily invest in these drugs as the returns on investment in orphan
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Expected to Post Quarterly Sales of $1.42 Billion
Brokerages expect Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report sales of $1.42 billion for the current quarter, according to Zacks Investment Research. Ten analysts have provided estimates for Alexion Pharmaceuticals’ earnings, with the highest sales estimate coming in at $1.49 billion and the lowest estimate coming in at $1.34 billion. Alexion Pharmaceuticals reported sales of $1.26 […]
Charles River Laboratories Adds George Llado to Board of Directors
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #boardofdirectors--Charles River Laboratories appoints George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, to its Board
Alexion Pharmaceuticals bid up on PE chatter (NASDAQ:ALXN)
Alexion Pharmaceuticals (ALXN +1.5%) breaks higher after being in negative territory for most of the morning. Betaville is suggesting that the company has
Top 6 Biotech Stocks For Traders
If you’re up for some speculative biotech trades, we are presenting the top 6 among our freshest picks of biotech stocks for the coming 12 months.
Follow Us